Everstone Capital
TMT
Everstone looks to strike control deal for digital marketing firm
Private equity firm Everstone Capital is in talks to acquire a controlling stake in digital marketing and information ......
General
InvAscent scores another exit from second fund
Healthcare-focused private equity firm InvAscent, which recently signed off from Hyderabad-based dermatology chain Oliva......
Finance
Everstone co-managed firm scripting plans for bigger corpus under second climate fund
EverSource Capital, a joint venture of Indian private equity firm Everstone Capital and the UK-based Lightsource BP, is ......
Finance
Sterile injectables manufacturer Maiva in talks to raise fresh capital
Maiva Pharma Pvt. Ltd is in talks with private equity investors, including buyout funds, to raise $60-70 million (₹485......
TMT
Everstone Capital eyes exit from IT services portfolio, looking at buyout firms
Homegrown private equity fund Everstone Capital is set to exit a bet in the IT space and is currently in ......
Consumer
Everstone Capital may look to acquire franchise owners to consolidate Subway brand
Everstone Capital, which recently has bagged the master franchise rights to expand Subway’s operations, is preparing a blueprint...
Infrastructure
Everstone mulls consolidating digital infrastructure biz for IPO
Everstone Group is looking to consolidate two of its businesses -- IndoSpace and EverYondr -- under a single entity as ......
Healthcare
PharmEasy founders pivoted thrice to make it big
For PharmEasy founder Siddharth Shah, building an e-pharmacy started out as a college project at the Indian Institute of Management...
Healthcare
PharmEasy's first investor Everstone Capital likely to make 8-10X on investment
Six years ago, PharmEasy founder Siddharth Shah met a top executive at Everstone Capital to make a pitch to raise ......
Finance
Everstone new fund bumps up PE firm's largest-ever corpus target, hits first close
Everstone Capital has bumped up the fundraise target for its fourth fund, which already had the largest corpus target ever ......









